News Announcement

Titan Bio-Tech: Statement Of Investors Complaints For The Quarter Ended 30Th June,2017.

Statement of Investors Complaints for the quarter ended 30th June, 2017 as required under Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.